RESVERLOGIX CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 CAD | 0.00% |
|
0.00% | -21.43% |
| Apr. 01 | Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 21 | Resverlogix Corp. Announces Resignation of Shawn Lu from the Board of Directors | CI |
Chart calendar Resverlogix Corp.
ab2c75b89660e511f7bdc7.1cJAdavglCJcycIHQd-BRoS4ScEQk2OS9pzlDZe04Z0.oZI5HsCi5mEljYBKd5W0J-7iA6lC-xXTm8m2b8DCiv6QnRY6_ZmlE2S_gw~96cd42a75f2163d06be957c9537d6530
Upcoming events on Resverlogix Corp.
Past events on Resverlogix Corp.
| 2024-04-01 09:05 am | Q4 2023 Earnings Release |
| 2023-08-11 06:50 pm | Q2 2023 Earnings Release |
| 2023-06-20 03:00 pm | Annual General Meeting |
| 2023-06-16 02:30 am | European Renal Association Meeting |
| 2023-05-11 | Q1 2023 Earnings Release |
| 2022-11-11 06:00 pm | Q3 2022 Earnings Release |
| 2022-08-12 06:01 pm | Interim 2022 Earnings Release |
| 2022-06-21 03:00 pm | Annual General Meeting |
| 2022-05-13 06:02 pm | Q1 2022 Earnings Release |
| 2022-03-31 06:33 pm | FY 2021 Earnings Release |
| 2022-03-10 01:00 pm | OTC Markets Group Inc Life Sciences Investor Forum |
| 2021-12-16 04:00 pm | Business Update Call |
| 2021-11-12 06:03 pm | Q3 2021 Earnings Release |
| 2021-11-12 | American Heart Association Scientific Sessions |
| 2021-11-08 | Clinical Trials on Alzheimer Disease Conference |
| 2021-11-01 | American Society of Nephrology Kidney Week Conference |
| 2021-10-22 01:30 pm | Benzinga ALL ACCESS International Conference |
| 2021-10-14 09:30 am | LD Micro Main Conference |
| 2021-08-16 07:01 pm | Interim 2021 Earnings Release |
| 2021-06-22 03:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 |
|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - |
|
EBIT Million CAD | Released Forecast Spread | -51,0 -46,8 -9.06% |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -214 -147 -45.93% |
|
Net income Million CAD | Released Forecast Spread | -214 -147 -45.82% |
|
EPS CAD | Released Forecast Spread | -1,15 -0,79 -45.35% |
| Announcement Date | 29/07/19 |
More events
Past sector events for Resverlogix Corp.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
- Stock Market
- Equities
- RVX Stock
- Calendar Resverlogix Corp.
